Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Consolidated Net Profit

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr₹1,377 Cr

What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?

The latest Consolidated Net Profit ratio of DIVIS LABORATORIES is ₹1,600 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,600 Cr
Mar2023₹1,824 Cr
Mar2022₹2,960 Cr
Mar2021₹1,984 Cr
Mar2020₹1,377 Cr

How is Consolidated Net Profit of DIVIS LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,600 Cr
-12.28
Mar2023 ₹1,824 Cr
-38.39
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr
44.15
Mar2020 ₹1,377 Cr -

Compare Consolidated Net Profit of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹163,028.9 Cr 4.3% 6.5% 63.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
MANKIND PHARMA ₹103,904.0 Cr -2.5% -8% 16.5% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

4.3%

6.5%

63.9%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses